Agendas including year-end dividend, partial AoI amendments, director appointments approved SEOUL, South Korea, March 25, 2025 /PRNewswire/ — KT&G (KRX: 033780) concluded the 38th annual general meeting of shareholders (AGM) on March 26, at the KT&G Human Development Center, during which…
Category: Uncategorized
Agendas including year-end dividend, partial AoI amendments, director appointments approved SEOUL, South Korea, March 25, 2025 /PRNewswire/ — KT&G (KRX: 033780) concluded the 38th annual general meeting of shareholders (AGM) on March 26, at the KT&G Human Development Center, during which…
JINAN, China, March 24, 2025 /PRNewswire/ — Recently, Professor Sun Jinpeng’s team at Shandong University and collaborators published a research paper titled “Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis” in Science. This study employed…
SHANGHAI, March 25, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced its financial…
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ — On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”or “the Group”; Stock Code: 600196.SH, 02196.HK), a leading global…
Driving Sustainable Healthcare with “CARE” Strategy HONG KONG and SHANGHAI, March 25, 2025 /PRNewswire/ — Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor”, “Ping An Health” or “the Company”, Stock Code: 1833.HK) recently released its 2024 Environmental, Social,…
GOODYEAR, Ariz., March 25, 2025 /PRNewswire/ — Jet MX, Inc. announced multiple business updates for maintenance solutions available to turbine jet aircraft owners and operators for popular types including Learjet, King Air and Hawker. The KGYR-based business introduced updated branding…
CHENGDU, China, March 25, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (formerly…
Built a differentiated portfolio and accelerated revenue growth with its independently developed reusable and automated design platform Secured key semiconductor IP and laid the foundation for long-term growth through next-generation technological innovations SEOUL, South Korea, March 25,…
RADNOR, Pa., March 25, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Integral Ad Science Holding Corp. (“IAS”) (NASDAQ: IAS) on behalf of those who purchased or…